search
developmental biology
Trends
- 1New Study Maps Human Meningeal Development in Detail▼Spatially resolved multiomics of human meningeal development reveal lineage and disease dynamics
Researchers publishing in Nature have used spatially resolved multiomics to map how the human meninges, the protective membranes surrounding the brain and spinal cord, develop. The work traces cell lineages during development and links them to disease dynamics, offering a reference for understanding neurological disorders tied to meningeal biology. It is being discussed among researchers following developmental biology and single-cell genomics.
- 2Bioweapons Development Alarms Experts Even Without AI▼There Are Plenty of Reasons to Be Concerned About Bioweapons Development—Even Without AI https:// fed.brid.gy/r/https://
A Wired report argues that concerns about biological weapons development do not depend on artificial intelligence, warning that existing biotechnology capabilities already pose serious risks. The piece suggests AI may worsen the danger, but the underlying threat of engineered pathogens and lax oversight stands on its own. The argument is prompting discussion about regulation and biosecurity.
- 3New benchmark tests how closely lab-grown embryo models match human development▼New computational benchmark reveals how closely lab-grown embryo models match real human development
Researchers have introduced a new computational benchmark designed to measure how accurately lab-grown human embryo models replicate real human embryonic development. The tool allows scientists to systematically compare stem-cell-derived embryo models against genuine developmental data, helping assess their fidelity and limitations. The work is being discussed in the bioengineering and developmental biology community as embryo models raise both scientific promise and ethical questions.
- 4BostonGene to Present AI Approach in Cancer Drug Development▼BostonGene Chief Medical Officer to Discuss Biologically Grounded AI and Multimodal Data in Oncology Drug Development at the 2nd Annual Global Cancer Research & Innovation Symposium
BostonGene's Chief Medical Officer is scheduled to speak at the 2nd Annual Global Cancer Research & Innovation Symposium, where the focus will be on biologically grounded artificial intelligence and the use of multimodal data in oncology drug development. The company argues that combining AI with biological context can improve how cancer therapies are discovered and developed.
- 5Scientists use light to correct faulty cell division▼LISA to the rescue: Using light to fix cell division
Researchers have introduced LISA, a light-based technique that can intervene in cell division when the process goes wrong, using light to control the machinery that separates chromosomes. Errors in cell division are linked to cancer and developmental problems, so an optical method that can correct or study the process in real time is drawing attention from biologists and medical researchers.
- 6Xenbase teams from Calgary and Cincinnati meet in Kananaskis●Xenbase University of Calgary and Cincinnati Children's team meeting, Kananaskis, Canada. # science # devbio # cellbio #
Researchers behind Xenbase, the Xenopus frog genome database, are holding a joint team meeting in Kananaskis, Canada, bringing together staff from the University of Calgary and Cincinnati Children's Hospital. The gathering covers developmental biology and cell biology topics, as the two groups coordinate work on the shared resource used by frog researchers worldwide.
- 7NAP1L1 Protein Found to Stabilize Gene Expression in Stem Cells●Histone Chaperone NAP1L1 Keeps Gene Expression Steady in Stem Cells
Researchers report that the histone chaperone NAP1L1 plays a key role in keeping gene expression stable in stem cells. By regulating how histones are assembled and handled, the protein helps maintain the precise gene activity patterns stem cells need to preserve their identity and function. The finding adds to understanding of the molecular machinery controlling stem cell behavior and could inform future research into regenerative medicine and developmental biology.
- 8Forge and TECPR2 Foundation Partner on AAV Gene Therapy●Forge, TECPR2 Research Foundation Strike AAV Gene Therapy Development, Manufacturing Partnership
Forge Biologics and the TECPR2 Research Foundation have announced a partnership covering the development and manufacturing of AAV-based gene therapy, aimed at advancing potential treatments for TECPR2-related genetic disorders. The deal combines Forge's manufacturing capabilities with the foundation's research focus, and observers in the biotech industry are watching it as a further example of nonprofits teaming up with contract manufacturers to accelerate rare-disease therapy programs.